entertainment -WSS

entertainment

author：explore 2025-10-01 22:58:40 - browse：9

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Class action alleges UnitedHealth concealed DOJ probe

hotspot

WSS

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Home health providers sue Medicare over payment cuts

Most antidepressants don't work on kids, teens, study finds

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

The U.S. needs a new definition of substance use “recovery”

Class action alleges UnitedHealth concealed DOJ probe

focus

entertainment

leisure time

Psychedelics group wrestles with new pharma identity

HHS's proposed rule does nothing to address the climate crisis

United colonoscopy coverage change 'may cost lives,' doctors say

Lawmakers grill UnitedHealth CEO on Change cyberattack

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Has Bernie Sanders reached the limit of his pharma bullying effort?

What does generative AI mean for health care? We asked experts

Warren pushes Witty on UnitedHealth's control over physicians

Moonlake's readout produced a cash windfall. Risks remain

PBM executives asked to testify by House panel

leisure time

The creative science of coining drug names

AI for drug discovery: Experts on separating hype from reality

Lawmakers grill UnitedHealth CEO on Change cyberattack

Biden declares emergency in flood

Home health providers sue Medicare over payment cuts

Welsh Carson private equity firm escapes from FTC antitrust case

focus

hotspot

knowledge

entertainment